Cargando…
Murine Models of Lysosomal Storage Diseases Exhibit Differences in Brain Protein Aggregation and Neuroinflammation
Genetic, epidemiological and experimental evidence implicate lysosomal dysfunction in Parkinson’s disease (PD) and related synucleinopathies. Investigate several mouse models of lysosomal storage diseases (LSDs) and evaluate pathologies reminiscent of synucleinopathies. We obtained brain tissue from...
Autores principales: | Clarke, Jennifer, Kayatekin, Can, Viel, Catherine, Shihabuddin, Lamya, Sardi, Sergio Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143154/ https://www.ncbi.nlm.nih.gov/pubmed/33919140 http://dx.doi.org/10.3390/biomedicines9050446 |
Ejemplares similares
-
Preclinical pharmacology of glucosylceramide synthase inhibitor venglustat in a GBA-related synucleinopathy model
por: Viel, Catherine, et al.
Publicado: (2021) -
Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson’s disease
por: Rockenstein, Edward, et al.
Publicado: (2016) -
No evidence for substrate accumulation in Parkinson brains with GBA mutations
por: Gegg, Matthew E., et al.
Publicado: (2015) -
Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis
por: Dodge, James C., et al.
Publicado: (2021) -
Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation
por: Bae, Eun-Jin, et al.
Publicado: (2015)